Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 3/20 | 0.32 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | PREP | P48147 | 1/20 | 0.31 |
| ▸ | FAP | Q12884 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20685675 | 0.86 | MTNR1A (0.32) | MTNR1AMTNR1BDPP4PREPFAP | |
| SCHEMBL23165445 | 0.86 | MTNR1A (0.32) | MTNR1AMTNR1BDPP4PREPFAP | |
| SCHEMBL20685659 | 0.86 | MTNR1A (0.32) | MTNR1AMTNR1BDPP4PREPFAP | |
| SCHEMBL23165447 | 0.86 | MTNR1A (0.32) | MTNR1AMTNR1BDPP4PREPFAP | |
| SCHEMBL23346524 | 0.84 | LMNA (0.35) | — | |
| SCHEMBL23346522 | 0.84 | FUCA1 (0.41) | MTNR1AMTNR1B | |
| SCHEMBL23346519 | 0.83 | MTNR1A (0.32) | MTNR1AMTNR1BDPP4PREPFAP | |
| SCHEMBL20685673 | 0.79 | MTNR1A (0.33) | MTNR1AMTNR1BDPP4PREPFAP | |
| SCHEMBL22005536 | 0.75 | MTNR1A (0.31) | MTNR1AMTNR1B | |
| SCHEMBL23346582 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210137881-A1 | BACTERIAL EFFLUX PUMP INHIBITORS | RUTGERS, THE STATE UNIVERISTY OF NEW JERSEY (US) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210137881-A1 | BACTERIAL EFFLUX PUMP INHIBITORS | ABCB11, ABCB1, SLC47A1 | MTNR1A 4030/4885MTNR1B 3864/4885DPP4 1744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.